The Strategy & Transformation Lead (Digital & AI) acts as a trusted advisor and execution partner to the Global Head of Digital Transformation, shaping and driving Fresenius Kabi’s Digital & AI strategy across business units.
The role sits at the intersection of Digital & AI strategy, portfolio steering, and organizational maturity tracking, ensuring that initiatives are aligned to business priorities, deliver measurable value, and are managed with full transparency across the enterprise.
1. Strategy Development
Conduct deep-dive analyses, external benchmarking, and technology trend monitoring
Translate strategic insights into clear opportunity spaces, identifying both functional and cross-functional Digital & AI use cases
Support definition of strategic priorities and investment areas
2. Portfolio Management
Structure and manage the Digital & AI initiative portfolio
Create transparency on:
Strategic priorities
Progress and KPIs
Dependencies and risks
Ensure alignment between strategy and execution, supporting fact-based decision-making at leadership level
3 . Change Management Auditing
Design and run periodic company-wide audits on Digital & AI maturity
Assess both: Technology adoption, ways of working and cultural evolution
Derive actionable insights and track transformation progress across business units
4. Strategic Support
Act as a trusted advisor and operational partner to the Global Head of Digital Transformation
Prepare and support leadership meetings and governance forums (e.g., steering committees)
Ensure alignment across stakeholders, proactively managing escalations and bottlenecks
Support ad-hoc strategic initiatives and special projects as required
Education:
Experience:
Capabilities:
Mindset & Ways of Working:
Language:
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint
